Alcon to acquire Belkin Vision for up to $335M

Alcon, a Swiss-American ophthalmology firm, has agreed to acquire Israeli glaucoma treatment company Belkin Vision for a total potential sum of $335 million, including an initial payment of $60 million and additional milestone payments.

“Alcon, the Swiss-American ophthalmology firm, is set to acquire Israeli glaucoma treatment company Belkin Vision for a total potential sum of $335 million.”jewisheconomist.com

• 1 source
• jewisheconomist.comAlcon's Acquisition of Belkin Vision: A Game-Changer in Glaucoma TreatmentMay 6, 2024

Summarized from public sources; check the original articles before acting on it.